ArticlePloS one2025
Happy or not? An investigative study on well-being and anhedonia in everyday life.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Music Therapy for Reduction of Anhedonia: Protocol for a Sequential Mixed Methods Pre-Post Pilot Study.JMIR research protocols · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anhedonia, the inability to experience pleasure or interest in activities, is a key symptom across various psychiatric disorders, including depression. It links to poor quality of life, higher suicide risk, and poorer prognosis. While anhedonia is often studied in clinical populations, its prevalence in healthy individuals and its dimensional nature remain underexplored. This study examined the prevalence of anhedonia in 128 German university students, comparing those with and without psychiatric symptoms and modeling psychiatric symptoms as predictor of anhedonia, measured with the Dimensional Anhedonia Rating Scale (DARS). Results showed that the clinical group demonstrated relatively low levels of anhedonia (total DARS-26: 85.03 ± 12.88) that did not differ from the healthy group (88.80 ± 7.88). Considerable variability suggests that a purely categorical approach to anhedonia may not capture its full complexity. Multiple regression analyses revealed that negative symptoms (e.g., affective flattening) were the strongest predictor of anhedonia, both in the full (b = -0.54, p < .001) and within the (sub-)clinical sample (b = -0.64, p < .001). Anxiety was also a significant predictor in the (sub-)clinical group (b = -1.06, p = .01), underscoring its impact on reward processing. Depression did not emerge as a strong predictor (b = -0.21, p = .49) when considered alongside other variables, indicating that its link to anhedonia may be mediated by other factors. Multigroup confirmatory factor analysis of the DARS showed that the 17-item version provided a better fit than the 26-item version, reinforcing the shorter version as a more efficient tool for assessing anhedonia. Taken together, the present findings support the use of a dimensional approach to anhedonia, which offers a more nuanced view of the underlying psychological and neurological mechanisms. Future research should explore anhedonia in larger, diverse samples for a comprehensive understanding of the link between anhedonia and mental illness. Registration: The study was pre-registered on OSF: https://doi.org/10.17605/OSF.IO/234A7.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.